However, ablation of hepatocyte-derived MCP-1 largely suppressed NASH diet–induced increase in liver Ccl2 (Figure 3B) and partially abrogated HSC activation and liver fibrosis (Figure 3, C–E). The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatohepatitis.